Document is current

Any future updates will be listed below

Cladribine-based debulking chemotherapy sequential with reduced intensity regimen and post-transplantation maintenance for refractory myeloid leukemia: a prospective phase II clinical trial

Crossref DOI link: https://doi.org/10.1038/s41409-022-01639-0

Published Online: 2022-03-29

Published Print: 2022-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark